Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: Results of a randomized, double-blind, active-controlled study (TRANSFORM-1) - Fedgchin, M; Trivedi, M; Daly, E (Int J Neuropsychopharmacol, 2019)
et al.